期刊文献+

黄连生物碱对金黄地鼠血脂代谢及低密度脂蛋白受体基因表达的影响 被引量:9

Effects of alkaloids from Coptidis Rhizoma on blood lipid metabolism and low-denstity lipoprotein receptor mRNA in golden hamsters
原文传递
导出
摘要 研究黄连生物碱对低密度脂蛋白受体(LDLR)基因表达和各项降脂指标的影响。通过实时荧光定量PCR检测给药后HepG2细胞和金黄地鼠肝脏中LDLR mRNA的表达量,同时检测给药前后血清总胆固醇(TC),甘油三酯(TG),低密度脂蛋白胆固醇(LDL-c),高密度脂蛋白胆固醇(HDL-c)含量。结果显示,给药后,与模型组相比,各药物组都有降血脂作用,其中黄连碱、巴马汀和药根碱能降低金黄地鼠血清中TC,TG和LDL-c水平(P<0.05,P<0.01),升高HDL-c(P<0.01),增加HepG2细胞和金黄地鼠肝脏中LDLR mRNA的表达量。表明黄连生物碱具有调节金黄地鼠血脂代谢的作用,且黄连碱的降脂效果最好。 To study the effects of alkaloids from Coptidis Rhizoma on low-density lipoprotein receptor(LDLR) mRNA expression and antihyperlipedemic levels. The LDLR mRNA expression were detected by real time fluorescence quantitative PCR, and the levels of total cholesterol(TC), triglyceride(TG), low density lipoprotein(LDL-c) and high-density lipoprotein cholesterol(HDL-c) in serum were measured at the first and last examination. The results show that, after the drug treatment, compared with the model group, each drug group showed a lipid-lowering effect. Especially, coptisine, palmatine, jatrorrhinze were significantly reduced TC, TG, LDL-c(P〈0.05, P〈0.01), and increased HDL-c(P〈0.01). In addition, they also increased mRNA expression of the LDLR in liver and HepG2 cells. The results showed that alkaloids from Coptidis Rhizoma can regulate lipid metabolism disorder,and coptisine have the best lipid-lowering effect.
出处 《中国中药杂志》 CAS CSCD 北大核心 2014年第11期2102-2105,共4页 China Journal of Chinese Materia Medica
基金 科技部支撑计划项目(2011BAI13B02-1) 2013年重庆市"百名工程技术高端人才培养计划"项目
关键词 黄连生物碱 LDLR mRNA 胆固醇 Coptidis Rhizoma alkaloids LDLR mRNA cholesterol
  • 相关文献

参考文献9

  • 1赵文华,张坚,由悦,满青青,李红,王春荣,翟屹,李莹,金水高,杨晓光.中国18岁及以上人群血脂异常流行特点研究[J].中华预防医学杂志,2005,39(5):306-310. 被引量:519
  • 2中国药典一部[S].2010年:32.
  • 3匡艳辉,朱晶晶,王智民,彭新君.黄连属药用植物化学成分和质量控制的研究进展[J].中国药学杂志,2008,43(15):1121-1125. 被引量:46
  • 4张志辉,邓安珺,于金倩,李志宏,吴练秋,王文杰,秦海林.黄连碱药理活性研究进展[J].中国中药杂志,2013,38(17):2750-2754. 被引量:54
  • 5Kong W J, Wei J, Zuo Z Y, et al. Combination of simvastatin with berberine improves the lipid-lowering efficacy [ J]. Metabolism, 2008,57 ( 8 ) : 1029.
  • 6Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-low- ering drug working through a unique mechanism distinct from st- atins [ J ]. Nat Med,2004,10 ( 12 ) : 1344.
  • 7Woo M N, Bok S H, Choi M S. Hypolipidemic and body fat-lower- ing effects of fatclean in rats fed a high-fat diet [ J ]. Food Chem Toxicol,2009,47 ( 8 ) :2076.
  • 8Yang T, Espenshade P J, Wright M E, et al. Crucial step in choles- terol homeostasis : sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER [ J ]. Cell,2002,110(4) :489.
  • 9Shitara Y, Sugiyama Y. Pharmacokinetic and pharmacodynamic al- terations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions [ J ]. Pharmacol Ther,2006,112 ( 1 ) :71.

二级参考文献30

共引文献1566

同被引文献92

引证文献9

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部